Pharmacovigilance

August 3, 2026

Pharmacovigilance Risk Assessment: A Practical Framework for Sponsors Managing Emerging Safety Risks

Pharmacovigilance Risk Assessment: A Practical Framework for Sponsors Managing Emerging Safety Risks 👤 Dr. Sornaraja Thasma | 🗓️ 03 Aug, 2026 | 📂 Pharmacovigilance Essential Pharmacovigilance Risk Assessment Framework for sponsors to assess emerging safety risks, evaluate signals, & make informed risk management decisions. Introduction: When a Safety Signal Becomes a Business Decision A safety...

by Dr. Sornaraja Thasma

July 21, 2026

Pharmacovigilance

PV Audit Preparation Frameworks for International Auditors

PV Audit Preparation Frameworks for International Auditors 👤 Dr. Sornaraja Thasma | 🗓️ 21 July, 2026 | 📂 Pharmacovigilance PV Audit Preparation Frameworks for International Auditors help sponsors and biotech companies prepare for successful global PV audits. Why Global PV Audit Readiness Is More Critical Than Ever Imagine receiving an audit notification from a global...

by Dr. Sornaraja Thasma

July 16, 2026

Pharmacovigilance

Literature Monitoring Strategies for Comprehensive PV Coverage

Pharmacovigilance Outsourcing Services: A Strategic Advantage for Pharmaceutical and Biotech Companies 👤 Dr. Sornaraja Thasma | 🗓️ 16 July, 2026 | 📂 Pharmacovigilance Discover how Pharmacovigilance Outsourcing Services help pharmaceutical and biotech companies improve compliance, manage safety operations, reduce costs, and scale global drug safety efficiently. The pharmaceutical and biotechnology industry is bringing innovative therapies...

by Dr. Sornaraja Thasma

July 16, 2026

Pharmacovigilance

Pharmacovigilance Outsourcing Services: A Strategic Advantage for Pharmaceutical and Biotech Companies

Pharmacovigilance Outsourcing Services: A Strategic Advantage for Pharmaceutical and Biotech Companies 👤 Dr. Sornaraja Thasma | 🗓️ 16 July, 2026 | 📂 Pharmacovigilance Discover how Pharmacovigilance Outsourcing Services help pharmaceutical and biotech companies improve compliance, manage safety operations, reduce costs, and scale global drug safety efficiently. The pharmaceutical and biotechnology industry is bringing innovative therapies...

by Dr. Sornaraja Thasma

July 13, 2026

Pharmacovigilance

ICSR Processing Optimization for Multi-Country Submissions

ICSR Processing Optimization for Multi-Country Submissions 👤 Dr. Sornaraja Thasma | 🗓️ 13 July, 2026 | 📂 Pharmacovigilance Optimize ICSR processing for faster multi-country safety submissions, stronger global compliance, and reduced regulatory risk across pharmaceutical markets. One ICSR Process Doesn’t Fit Every Country Bringing a medicinal product to global markets means far more than obtaining...

by Dr. Sornaraja Thasma

July 1, 2026

Pharmacovigilance

PSUR Harmonization Across FDA, EMA, and CDSCO Requirements

PSUR Harmonization Across FDA, EMA, and CDSCO Requirements 👤 Dr. Sornaraja Thasma | 🗓️ 1July, 2026 | 📂 Pharmacovigilance Introduction As pharmaceutical products increasingly move across international markets, pharmacovigilance teams face growing pressure to maintain consistent safety reporting while meeting the unique expectations of different regulatory authorities. Among the most important post-marketing obligations is the...

by Dr. Sornaraja Thasma

June 22, 2026

Pharmacovigilance

A Sponsor’s Guide to Signal Detection for IND, NDA, BLA, and Post Marketing Programs

A Sponsor’s Guide to Signal Detection for IND, NDA, BLA, and Post Marketing Programs 👤 Dr. Sornaraja Thasma | 🗓️ 22 June 2026 | 📂 Pharmacovigilance Introduction Every successful drug development program is built on a foundation of patient safety. From the first patient enrolled in a clinical trial to years after a product reaches...

by Dr. Sornaraja Thasma

March 31, 2026

Pharmacovigilance

Risk Management Plans Integration in Global Development Programs

Risk Management Plans Integration in Global Development Programs 👤 Dr. Sornaraja Thasma | 🗓️ 31 March, 2026 | 📂 Pharmacovigilance Introduction In global development programs, integrating Risk Management Plans has become a defining requirement for demonstrating patient safety, regulatory responsibility, and lifecycle oversight. The increasing complexity of therapies, expansion into multi-regional trials, and heightened regulatory...

by Dr. Sornaraja Thasma

March 16, 2026

Pharmacovigilance

PBRER vs PSUR: Key Differences Explained

PBRER vs PSUR: Key Differences Explained 👤 Dr. Sornaraja Thasma | 🗓️ 16 March, 2026 | 📂 Pharmacovigilance Pharmacovigilance plays a critical role in ensuring that medicines remain safe and effective after they reach the market. Once a drug receives marketing authorization, pharmaceutical companies must continue monitoring its safety profile using structured regulatory reports. Two...

by Dr. Sornaraja Thasma

March 4, 2026

Pharmacovigilance

Global Signal Detection Trends Transforming Drug Safety 2026

Global Signal Detection Trends Transforming Drug Safety-2026 👤 Dr. Sornaraja Thasma | 🗓️ 4 March, 2026 | 📂 Pharmacovigilance Abstract As the pharmaceutical landscape becomes increasingly complex in 2026, global signal detection is emerging as a critical component of drug safety. Advanced therapies, biologics, and personalized medicine require proactive monitoring strategies that go beyond traditional...

Our Presence

USA | India

Email Us

info@atvigilx.com

Stay Updated with Atvigilx For Expert Pharmacovigilance, Regulatory Affairs & GCP Insights

Quick Links:

Services:

Request for Proposal

Copyright © 2024 Reserved at ProRelix Services LLP